12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor-Deficient Mice
O xidative processes have been shown to play a dominant role in the initiation and progression of atherosclerosis in animal models. 1, 2 Several lines of evidence support this contention. Oxidation-specific epitopes have been detected within the atherosclerotic plaque. In addition, in vitro studies have demonstrated that oxidized LDL (oxLDL) rather than native LDL is capable of promoting smooth muscle cell migration and endothelial, lymphocyte, and macrophage activation, properties that may explain its proatherogenic properties (reviewed by Heinecke 3 ). Probably the most significant support for the oxidation hypothesis derives from studies showing that antioxidant administration reduces atherogenesis in various animal models. 2 Two recent studies suggest that administration of vitamin E may be capable of reducing coronary heart disease events in humans, 4, 5 although in 3 other studies, it was found to be ineffective. 6 -8 Indirect results have incriminated several candidates in promoting oxidative modification, such as NADPH oxidase, myeloperoxidase, some cytochrome P450 members, the mitochondrial electron transport system, xanthine oxidase, and lipoxygenases (LOs) (reviewed in Reference 3). In contrast to the relatively strong evidence for the role of oxLDL in atherosclerosis, however, there is little or no evidence regarding the systems that oxidize LDL in vivo.
LOs are a family of non-heme iron-containing dioxygenases that insert molecular oxygen into polyenoic fatty acids. 9 This family includes the human and rabbit 15-LOs, as well as the porcine, rat, and murine leukocyte-type 12-LOs, all of which can directly oxidize esterified fatty acids in lipoproteins and phospholipids. 10 The latter enzymes are also called 12/15-LO, because they are capable of producing both 12-hydroperoxy-eicosatetraenoic acid (12-HPETE) and 15-HPETE from arachidonic acid. There is a close structural resemblance between 15-LO and 12/15-LO, because minor alterations in amino acid sequence can account for the species differences in oxygen insertional specificity. 11 The involvement of LO in atherosclerosis is supported by indirect, as well as direct, in vivo observations. 15-LO was found to be present within atherosclerotic plaques of humans and rabbits, colocalizing with oxidation epitopes. 12 The powerful data supporting involvement of LO in atherogenesis, however, come from animal studies. Initial observations have shown that overexpression of 15-LO in rabbit arteries was associated with increased occurrence of oxLDL epitopes. 13 We recently showed that overexpression of human 15-LO in endothelial cells of the vessel wall of LDL receptor-deficient (LDL-R Ϫ/Ϫ ) mice via preproendothelin promoter resulted in acceleration of early atherosclerotic lesions. 14 Two recent studies have demonstrated that pharmacological inhibition of 15-LO resulted in attenuation of atherosclerosis in hypercholesterolemic rabbits. 15, 16 Probably the most conclusive evidence for the role of 12/15-LO in atherosclerosis to date comes from the study by Cyrus et al 17 showing that disruption of the 12/15-LO gene in apoEknockout mice significantly retarded atherosclerosis initiation and progression. Data from Shen et al, 18 however, indicate that overexpression of 15-LO in rabbit macrophages is associated with reduced atherogenesis, thus questioning the proatherogenic role of 15-LO. 19 In the present study, we obtain further evidence for the role of 12/15-LO in murine atherogenesis by studying 12/15-LO gene disruption in LDL-R Ϫ/Ϫ mice using 2 different types of high-fat diet in 2 laboratories (in Israel and the United States). The different experimental protocols of diet feeding are intended to induce either fatty streaks or more advanced lesions. mice was previously described. 20, 21 12/15-LO Ϫ/Ϫ mice on a hybrid C57BL/6ϫ129/Sv (Israeli colony) or backcrossed to C57BL/6 (7 times) (University of Pennsylvania colony) background were crossbred with LDL-R Ϫ/Ϫ mice. Mice were genotyped either by polymerase chain reaction analysis (LDL-R Ϫ/Ϫ ) or Southern blot analysis (12/15-LO) as described. 21 All mice were kept on a 12-hour light/12-hour dark cycle, and food and water were available ad libitum. At the age of 11 to 12 weeks, LDL-R/12/15-LO-doubleknockout and LDL-R Ϫ/Ϫ mice were fed a Western-type diet. Mice were euthanized 3 to 18 weeks after initiation of the diet, and their hearts and aortas were removed for evaluation of the extent of atherosclerosis. Plasma was obtained for assessment of the lipid profile in all mice.
Methods

Generation of LDL-R
Diets
1. The Paigen-type diet contained 1.25% cholesterol, 7.5% casein, and 0.5% (wt/wt) sodium cholate (Harlan, Teklad Premier Laboratory Diets).
2. The Western-type diet contained 42% of calories from fat, 43% from carbohydrates, and 15% from protein (TD 96125, Harlan Teklad).
Lipid Profile
Total plasma cholesterol and triglyceride levels were determined with an automated enzymatic technique (Boehringer Mannheim). HDL cholesterol levels were determined by HDL cholesterol reagent (Sigma Chemical Co).
Lipoprotein Oxidation
Blood for lipoprotein isolation was collected in EDTA (1 mg/mL) from 3 pools from 3 mice in each group after 12 hours of fasting. LDL (density 1.019 to 1.063 g/L) was isolated from the plasma after density adjustment with KBr Ϫ , by preparative ultracentrifugation at 50 000 rpm/min for 22 hours with a type 50 rotor. LDL preparations were washed by ultracentrifugation, dialyzed against 0.15 mol/L EDTA (pH 7.4), passed through an Acrodisc filter (0.22-m pore size) to remove aggregates, and stored under nitrogen in the dark. Copper oxidation of LDL was performed by incubation of postdialysis LDL (1 mg protein/mL in EDTA-free PBS) with copper sulfate (10 mol/L) for 24 hours at 37°C. Lipoprotein oxidation was confirmed by analysis of thiobarbituric acid-reactive substances (TBARS). 22 
Assessment of Atherosclerosis in the Aortic Sinus
Atherosclerotic fatty-streak lesions were quantified by measurement of the lesion size in the aortic sinus as previously described. 23 The heart and upper section of the aorta were removed from the animals, and the peripheral fat was cleaned carefully. The upper section was embedded in O.C.T. compound (Miles Inc) and frozen. Every other section (10 m thick) throughout the aortic sinus (400 m) was taken for analysis. Sections were evaluated for fatty-streak lesions after staining with oil red O. Lesion areas per section were counted by use of a grid by an observer unfamiliar with the tested specimen.
Sudan IV Staining of Aortic Lesions
The aortas were dissected from the aortic arch to the iliac bifurcation and washed for 1 hour in PBS (pH 7.4) and 0.5 mmol/L EDTA on a rotating table. 24 The aorta was then fixed with a formal sucrose (4% paraformaldehyde, 5% sucrose, 20 mmol/L butylated hydroxytoluene, and 2 mmol/L EDTA, pH 7.4) overnight. The adventitial fat was trimmed from the aorta under a microscope and opened longitudinally, rinsed briefly in 70% ethanol, immersed for 6 minutes in a filtered solution of Sudan IV (Sigma Chemical Co) in 35% ethanol and 50% acetone for 10 minutes, and destained in 80% ethanol. 25 The Sudan IV-stained aortas were assessed for lesion area by morphometry as previously described. 24 
Immunohistochemical Analysis of Aortic Sinus Sections
Immunohistochemical stainings were performed as described 26 with the following primary antibodies: rat anti-mouse CD3 clone: 17A2 (PharMingen), rat anti-mouse VCAM-1 (clone 429 MVCAM.A, PharMingen), and rat anti-mouse Mac-1 (clone M1/70, Boehringer Mannheim). Slides were dried under airstream for 45 minutes, fixed in acetone for 5 minutes in Ϫ20°C, and rinsed 3 times for 5 minutes in Tris-buffered saline (TBS) containing 0.1% BSA and 0.05% Tween-20 (TBS-BSA-Tween). To reduce background signals, a 15-minute incubation with 10% nonimmune goat serum was followed by a 30-minute incubation with CAS (Zymed Laboratory) at room temperature. After blocking, the various primary antibodies diluted 1:50 in TBS-BSA-Tween, biotinylated second antibody, and streptavidin peroxidase conjugate (a kit from Zymed Laboratory) were added. The results of the Mac-1 and CD3 cells are expressed as positive nuclei/total plaque nuclei.
Statistical Analysis
Differences between groups with respect to lipid levels and plaque size and composition were made with a 2-sided Student's t test. A value of PϽ0.05 was considered statistically significant.
Results
LDL-R-deficient mice maintain relatively moderate hypercholesterolemia and do not develop significant atherosclerosis on feeding a normal chow diet. Feeding a Paigen diet facilitates atherosclerosis concomitant with the elevation of cholesterol levels. The LDL-R-deficient mouse model, similar to the apoE-knockout model, displays features that indicate the involvement of oxidation in enhanced atherogenesis.
LDL-R Ϫ/Ϫ /12/15-LO Ϫ/Ϫ mice, like LDL-R Ϫ/Ϫ littermates, were healthy and fertile, gaining weight in a similar manner regardless of the diet provided.
After 3 weeks and 9 weeks on the high-fat diet, LDL-R Ϫ/Ϫ /12/15-LO Ϫ/Ϫ -double-knockout mice and LDL-R Ϫ/Ϫ controls (12/15-LO ϩ/ϩ ) maintained similar levels of cholesterol and triglycerides (Table) . Figure 1 ). To further confirm the results of aortic root atherogenesis, we assessed the extent of atherosclerosis throughout the aortas by en face methodology. Because our previous observations indicated that after 3 weeks on a high-fat diet, no quantifiable lesions were observed throughout the aorta, lesions were evaluated after 9, 12, and 18 weeks of diet. Indeed, aortic surface lesion coverage was significantly reduced in LDL-R Figure 3 ). More advanced lesions (9 weeks of high-fat diet) from 12/15-LO Ϫ/Ϫ mice were also found to exhibit a content of macrophages (82.5Ϯ5.5%) similar to that of control mice (73.5Ϯ6.6%). No differences were observed in the lymphocyte (CD3 ϩ ) content between lesions of LDL-R Ϫ/Ϫ /12/15-LO Ϫ/Ϫ mice fed a Paigen diet for 3 weeks (3.0Ϯ1.1%) and control mice (2.6Ϯ1.0%; Figure 3 ) or 9 weeks (4.1Ϯ1.1% and 3.2Ϯ0.7%, respectively).
Discussion
In the present study, we address the role of 12/15-LO expression in atherogenesis. The optimal means of testing the hypothesis that this enzyme is proatherogenic is by crossbreeding experiments, identifying the effects of isolated gene disruptions. Indeed, Cyrus et al 17 
The mice were fed a high-cholesterol, high-fat diet. Animals (nϭ10 or 11) from each group were bled at 0, 3, 6, and 9 weeks in 2 independent studies. Plasma cholesterol and triglyceride concentrations were determined as described in Methods. Values are meanϮSEM. LDL-R Ϫ/Ϫ mice were fed a Paigen diet for 3 and 9 weeks. At death, hearts were removed and sectioned at level of aortic sinus for evaluation of atherosclerotic lesion development after staining with oil red O (A and B). After high-fat diet for 9 weeks, aortas were removed, cleaned, and stained with Sudan IV as described in Methods for evaluation of aortic coverage (C). *PϽ0.01; **PϽ0.001; ***PϽ0.0001.
tions in which overexpression of the human 15-LO gene in the vessel walls of LDL-R Ϫ/Ϫ mice by use of the relatively endothelium-specific preproendothelin promotor enhanced early atherogenesis. 14 Other than supporting the role of LO in atherogenesis, this study also indicated a relevant cellular compartment (ie, the endothelial cell) that could participate in LO-mediated oxidative modification culminating in accelerated atherosclerosis. These studies, however, are challenged by results from Shen et al 18 showing that overexpression of 15-LO in rabbit macrophages results in suppression of plaque formation. The explanations that have been provided for the apparently conflicting results include the different animal models (rabbits versus mice) and the specific cellular target (macrophages) used by Shen et al. 18 In the present study, we found that disruption of the 12/15-LO gene resulted in diminished atherosclerotic lesion formation induced by high-fat diet in LDL-R Ϫ/Ϫ mice, consistent with the findings in apoE-knockout mice. It appeared that the differences in early lesion formation in our present study were relatively less pronounced than those obtained by Cyrus et al 17 that explored spontaneous hypercholesterolemia in apoE-knockout mice. These differences may be explained by the use of a high-fat diet in our experiment that resulted in total cholesterol levels that significantly exceeded those obtained in the apoE Ϫ/Ϫ study, 17 thus possibly partially overwhelming the isolated effect of 12/15-LO-mediated LDL oxidation. As in the previous work, 17 however, we also found that the 12/15-LO gene disruption did not appear to influence the lipid profile, thus excluding this factor as a possible explanation for the reduced lesion formation.
Several explanations have been provided for the mechanisms by which the cytosolic 12/15-LO enzyme could mediate extracellular LDL oxidation. 27 Hydroperoxides formed by LO could be transferred across the cell membrane, thereby contacting extracellular LDL. This is supported by the observation that incubation of LDL with fibroblasts transfected with 15-LO enhances generation of lipid hydroperoxides. 28 -30 Alternatively, 12/15-HETE produced by local monocytemacrophage activation could serve as ligand for peroxisome proliferator-activated receptor-␥, resulting in CD36 (a candidate scavenger receptor for oxLDL) upregulation with a consequent enhanced plaque formation. 31, 32 Regardless of the mechanism, LO-generated products may also contribute to atherosclerosis by inducing a proinflammatory state by recruitment of macrophages and T lymphocytes and activating the cells already present within the lesion. Indeed, T-cell activation has been shown to occur within the atherosclerotic plaque, 33 and CD4-positive clone-producing T-helper type 1 cytokines (interferon-␥) have been isolated from human lesions. 34 To explore the relevance of this possibility in our model, we performed a quantitative analysis of the cellular components within the lesions. The results indicate that cellular composition was similar between LDL-R Ϫ/Ϫ /12/15-LO Ϫ/Ϫ and LDL-R Ϫ/Ϫ mice, as reflected by the total macrophage and T-lymphocyte numbers within the lesions.
In conclusion, our results demonstrate that 12/15-LO gene disruption reduces atherosclerosis in LDL-R Ϫ/Ϫ mice without influencing plaque composition. These data reinforce previous observations in the apoE mouse and indicate that 12/ 15-LO inhibition could represent an attractive treatment strategy for atherosclerosis.
The mice were fed a high-cholesterol, high-fat diet. Animals (nϭ10 to 11) from each group were bled at 0, 3, 6, and 9 weeks in 2 independent studies. Plasma cholesterol and triglyceride concentrations were determined as described in Methods. Results represent the meanϮSEM.
Acknowledgment
This study was supported in part by NIH grant HL-53558 (Dr Funk). 
